New-Onset Postoperative Atrial Fibrillation and Long-Term Survival After Aortic Valve Replacement Surgery Giovanni Filardo, PhD, MPH, Cody Hamilton,

Slides:

Advertisements

Similar presentations

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease Srikrishna Sirivella, MD, Isaac Gielchinsky,

Advertisements

Impact of Chronic Kidney Disease on Long-Term Outcomes in Type 2 Diabetic Patients With Coronary Artery Disease on Surgical, Angioplasty, or Medical Treatment

Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.

Six-month–adjusted survival after aortic valve replacement (AVR) for severe aortic stenosis (AS) stratified by procedure and preoperative ejection fraction.

Longitudinal Outcome of Isolated Mitral Repair in Older Patients: Results From 14,604 Procedures Performed From 1991 to 2007 Vinay Badhwar, MD, Eric.

Manuel Caceres, MD, Darryl S. Weiman, MD, JD

Long-Term Outcome of Coronary Artery Bypass Grafting in Patients With Left Ventricular Dysfunction Paolo Nardi, MD, PhD, Antonio Pellegrino, MD, Antonio.

Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M

Predictors of 30-day hospital readmission after coronary artery bypass

Increased late mortality after coronary artery bypass surgery complicated by isolated new-onset atrial fibrillation: A comprehensive propensity-matched.

Fred H. Edwards, MD, David M. Shahian, MD, Maria V

Should Bilateral Internal Thoracic Artery Grafting Be Used in Patients With Diabetes Mellitus? Dmitry Pevni, MD, Benjamin Medalion, MD, Rephael Mohr,

One or Two Internal Thoracic Grafts

Clinical Profile and Natural History of 453 Nonsurgically Managed Patients With Severe Aortic Stenosis Padmini Varadarajan, MD, Nikhil Kapoor, MD, Ramesh.

Postoperative Atrial Fibrillation Is Associated With High On-Aspirin Platelet Reactivity Tomislav Kopjar, MD, PhD, Mate Petricevic, MD, PhD, Hrvoje Gasparovic,

James Edgerton, MD, Giovanni Filardo, PhD, MPH, William H

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery Farkas B. Vánky, MD, PhD, Erik.

Self-Management of Anticoagulant Therapy in Mechanical Heart Valve Patients: A Matched Cohort Study Thomas Decker Christensen, MD, PhD, Flemming Skjøth,

Should We Ablate Atrial Fibrillation During Coronary Artery Bypass Grafting and Aortic Valve Replacement? Talal Al-Atassi, MD, MPH, Donna-May Kimmaliardjuk,

Comparing Long-Term Survival Between Patients Undergoing Off-Pump and On-Pump Coronary Artery Bypass Graft Operations Giovanni Filardo, PhD, MPH, Paul.

Predicting New-Onset Post-Coronary Artery Bypass Graft Atrial Fibrillation With Existing Risk Scores Benjamin D. Pollock, PhD, MSPH, Giovanni Filardo,

The Impact of Peripheral Vascular Disease on Long-Term Survival After Coronary Artery Bypass Graft Surgery Danny Chu, MD, Faisal G. Bakaeen, MD, Xing.

Trends in Acute Kidney Injury, Associated Use of Dialysis, and Mortality After Cardiac Surgery, 1999 to 2008 Colin R. Lenihan, MBBCh, BAO, Maria E. Montez-Rath,

Shikhar Agarwal, MD, MPH, Aatish Garg, MD, Akhil Parashar, MD, Lars G

Robert E. Freundlich, MD, MS, Michael D. Maile, MD, MS, Mark M

Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy Eric J. Velazquez, MD,

Does Prior Coronary Bypass Surgery Present a Unique Risk for Reoperative Valve Surgery? Andrew Breglio, BS, Anelechi Anyanwu, MD, Shinobu Itagaki, MD,

Three-Year Outcomes of Multivessel Revascularization in Very Elderly Acute Coronary Syndrome Patients Brett C. Sheridan, MD, Sally C. Stearns, PhD, Joseph.

Chronic Atrial Fibrillation Is Associated With Reduced Survival After Aortic and Double Valve Replacement Richard Schulenberg, MD, Polychronis Antonitsis,

Donald S. Likosky, PhD, Stephen D. Surgenor, MD, Robert S

Impact of Extracardiac Vascular Disease on Vein Graft Failure and Outcomes After Coronary Artery Bypass Surgery Ralf E. Harskamp, MD, John H. Alexander,

Potassium and Magnesium Supplementation Do Not Protect Against Atrial Fibrillation After Cardiac Operation: A Time-Matched Analysis Timothy S. Lancaster,

Enhancing the Value of Population-Based Risk Scores for Institutional-Level Use Sajjad Raza, MD, Joseph F. Sabik, MD, Jeevanantham Rajeswaran, PhD, Jay.

Established Preoperative Risk Factors Do Not Predict Long-Term Survival in Isolated Coronary Artery Bypass Grafting Patients Giovanni Filardo, PhD, MPH,

Observational Study on the Beneficial Effect of Preoperative Statins in Reducing Atrial Fibrillation After Coronary Surgery Giovanni Mariscalco, MD,

Jeremiah R. Brown, PhD, Richard P. Cochran, MD, Todd A

Predictors of Low Cardiac Output Syndrome After Isolated Coronary Artery Bypass Surgery: Trends Over 20 Years Khaled D. Algarni, MD, MHS, Manjula Maganti,

Ruben L. Osnabrugge, MS, Alan M. Speir, MD, Stuart J

Percutaneous Intervention Before Coronary Artery Bypass Surgery Does Not Unfavorably Impact Survival: A Single-Center Propensity-Matched Analysis Suvitesh.

Impact of Preoperative Symptoms on Postoperative Survival in Severe Aortic Stenosis: Implications for the Timing of Surgery Sophie Piérard, MD, Christophe.

Costs Five Years After Off-Pump or On-Pump Coronary Artery Bypass Surgery Todd H. Wagner, PhD, Brack Hattler, MD, Faisal G. Bakaeen, MD, Joseph F. Collins,

Long-Term Survival After Coronary Arterial Grafts in Patients With End-Stage Renal Disease Taro Nakatsu, MD, Nobushige Tamura, MD, PhD, Yutaka Sakakibara,

Aortic Valve Replacement and Concomitant Coronary Artery Bypass: Assessing the Impact of Multiple Grafts Kimiyoshi J. Kobayashi, BS, Jason A. Williams,

Extracorporeal Membrane Oxygenation for Advanced Refractory Shock in Acute and Chronic Cardiomyopathy Christian A. Bermudez, MD, Rodolfo V. Rocha, MD,

Alexander Iribarne, MD, MS, Anthony W. DiScipio, MD, Jock N

Do the EXCEL and NOBLE Trial Results Change Meta-Analysis Findings?

Aortic Valve Replacement for Patients With Severe Aortic Stenosis: Risk Factors and Their Impact on 30-Month Mortality Edward L. Hannan, PhD, Zaza Samadashvili,

Outcomes of Dialysis-Dependent Patients After Cardiac Operations in a Single-Center Experience of 483 Patients Sergey Leontyev, MD, PhD, Piroze M. Davierwala,

Association of Body Mass Index With New-Onset Atrial Fibrillation After Coronary Artery Bypass Grafting Operations Xiumei Sun, MD, Steven W. Boyce, MD,

Stent Versus Off-Pump Coronary Bypass Grafting in the Second-Generation Drug- Eluting Stent Era Gijong Yi, MD, PhD, Hyun-Chel Joo, MD, Young-Nam Youn,

Limitations of Hospital Volume as a Measure of Quality of Care for Coronary Artery Bypass Graft Surgery Karl F. Welke, MD, Mitchell J. Barnett, PharmD,

Survival After Isolated Coronary Artery Bypass Grafting in Patients With Severe Left Ventricular Dysfunction Waleed A. Ahmed, MD, Phillip J. Tully, BHSc(Hons),

Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population Christian McNeely, MD, Stephen.

Guidance for the use of bilateral internal thoracic arteries according to survival benefit across age groups Umberto Benedetto, MD, PhD, Mohamed Amrani,

Defining Patient-Prosthesis Mismatch and Its Effect on Survival in Patients With Impaired Ejection Fraction David A. Cotoni, DO, Robert T. Palac, MD,

Total Arterial Off-Pump Coronary Surgery: Time to Change Our Habits?

Effect of Coronary Artery Disease Extent on Contemporary Outcomes of Combined Aortic Valve Replacement and Coronary Artery Bypass Graft Surgery Zhongmin.

On-Pump Versus Off-Pump Surgical Revascularization for Left Main Stem Stenosis: Risk Adjusted Outcomes John C.Y. Lu, Antony D. Grayson, BS, D. Mark Pullan

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

Lung Transplantation and Coronary Artery Disease

Variation in mortality risk factors with time after coronary artery bypass graft operation Dexiang Gao, PhD, Gary K Grunwald, PhD, John S Rumsfeld, MD,

Potassium and Magnesium Supplementation Do Not Protect Against Atrial Fibrillation After Cardiac Operation: A Time-Matched Analysis Timothy S. Lancaster,

Reoperation for Coronary Artery Bypass Grafting Surgery: Outcomes and Considerations for Expanding Interventional Procedures Simon Maltais, MD, PhD,

Assessment of independent predictors for long-term mortality between women and men after coronary artery bypass grafting: Are women different from men?

Donald S. Likosky, PhD, Lawrence J. Dacey, MD, Yvon R

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery Chuntao Wu, MD, PhD, Edward L. Hannan,

Left Ventricular End-Diastolic Pressure Predicts Survival in Coronary Artery Bypass Graft Surgery Patients Jeevan Nagendran, MD, PhD, Colleen M. Norris,

Kim I. de la Cruz, MD, Faisal G

Magnus Dalén, MD, Torbjörn Ivert, MD, PhD, Martin J

Presentation transcript:

New-Onset Postoperative Atrial Fibrillation and Long-Term Survival After Aortic Valve Replacement Surgery Giovanni Filardo, PhD, MPH, Cody Hamilton, PhD, Baron Hamman, MD, Robert F. Hebeler, MD, John Adams, MPH, Paul Grayburn, MD The Annals of Thoracic Surgery Volume 90, Issue 2, Pages 474-479 (August 2010) DOI: 10.1016/j.athoracsur.2010.02.081 Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Unadjusted (Kaplan-Meier) curves depicting the effect of new-onset postoperative atrial fibrillation on survival in patients who underwent aortic valve replacement surgery and survived past the day of surgery at Baylor University Medical Center (Dallas, TX) United States between January 1997 and December 2006. (Afib = patient with new-onset postoperative atrial fibrillation; No Afib = patient without new-onset postoperative atrial fibrillation.) The Annals of Thoracic Surgery 2010 90, 474-479DOI: (10.1016/j.athoracsur.2010.02.081) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Adjusted (proportional hazard model) curves and 95% confidence intervals depicting the effect of new-onset postoperative AF on survival in patients who underwent aortic valve replacement surgery and survived past the day of surgery at Baylor University Medical Center (Dallas, TX) United States between January 1997 and December 2006. The propensity adjusted model includes the following risk factors: age, gender, body surface area, race, diabetes, preoperative renal failure, preoperative creatinine level, chronic lung disease, hypertension, peripheral vascular disease, cerebrovascular disease, endocarditis, smoking status, congestive heart failure, previous revascularization procedure (percutaneous coronary intervention or CABG), previous valve surgery, myocardial infarction timing (time since myocardial infarction), ejection fraction, left main disease, urgency of operation (elective or nonelective), and concomitant procedure (CABG). For the purposes of the adjusted curves, all factors are set to their mean values. (Afib = patient with new-onset postoperative AF; No Afib = Patient without new-onset postoperative atrial fibrillation; AF = atrial fibrillation; CABG = coronary artery bypass grafting.) The Annals of Thoracic Surgery 2010 90, 474-479DOI: (10.1016/j.athoracsur.2010.02.081) Copyright © 2010 The Society of Thoracic Surgeons Terms and Conditions